All News

While ASCO is calling to update the 340B drug discount program, hospitals that serve economically diverse populations make a case for the program: "Because of 340B, we don't have to turn patients away when they can't pay."

The American Society of Hematology has added 5 more recommendations to it's Choosing Wisely list, which was published in the journal Blood,

With the share of Medicaid beneficiaries enrolled in managed care past the halfway mark, a new online tool from the Kaiser Family Foundation will help policymakers and researchers track its status in 39 states.

Health information exchange (HIE) use is increasing in the US, but other than reducing emergency department usage and costs, little else is known about the effect of HIEs on other outcomes, according to a new study from RAND.

The study, published in NEJM, found that PFS improved by nearly 4 months while ORR improved by nearly 30%.

By distinguishing low- and intermediate-risk patients, Oncotype DX is predicted to avoid over- and under-treatment of prostate cancer patients.

The 3.6% increase in US healthcare spending in 2013 marks the lowest growth in healthcare spending since 1960, according to a report from CMS published in Health Affairs.

Blincyto, which was considered a promising immunotherapy with a novel mechanism of action, was approved 5 months prior to its PDUFA date.

The National Institutes of Health issued a draft policy today to promote the use of single institutional review boards in multi-site clinical research studies.

Patients on exchange plans are more likely to see higher out-of-pocket costs for their specialty drugs in 2015 compared with 2014, according to a new analysis from Avalere Health.

Rules issued today will help CMS keep fraudulent providers and suppliers away from Medicare, following a series of crackdowns in "hot spots" around the country.

Absence of a microRNA in TNBC resulted in the overexpression of RASAL2 in those tumors. Patients overexpressing RASAL2 had poorer survival, research showed.

People could be putting their lives at risk by dismissing potential warning signs of cancer as less serious symptoms, according to a Cancer Research UK-funded study published in PLOS ONE. The survey found that nearly 97% of people with symptoms failed to act on them.

Although there are no current cases of Ebola in the United States, an increased number of hospitals are now equipped to treat patients with the virus while minimizing risk to healthcare workers.

A study found new indications for a drug that is widely used in the treatment of osteoarthritis, based on an observation that those on the medication had a lower incidence of several cancers.

The 3-year pilot is expected to reel-in significant cost savings for Medicare, which has seen a lot of fraudulent charges with services and equipment.

Employers and employees are seeing eye-to-eye when it comes to integrated health benefits. Not only do employees see how an integrated plan can improve quality of care and health, but employers see how it makes good business sense.

Efforts to improve patient safety in hospitals are paying off: there were 1.3 million fewer adverse events harming patients in 2011, 2012, and 2013, according to a new report from HHS.

President Obama is scheduled to visit NIH today to highlight recent results on a potential Ebola vaccine, developed with GlaxoSmithKline. He is expected to call on Congress to pass a $6.2 billion package to combat the current crisis and prevent future outbreaks.

Dr Kavita Patel, a practicing physician and a policy researcher at the Brookings Institution, writes in her opinion piece that Obamacare has achieved it's purported goals.

Iressa, an EGFR inhibitor, is widely used in the treatment of advanced, metastatic NSCLC.

Among the dozen revisions to the Medicare Shared Savings Program being considered includes one that could bring some relief to accountable care organizations facing penalties for poor performance.

Failure of the drug in the phase 3 COMET-2 study was anticipated following the reported failure of the earlier COMET-1 trial.

Patient satisfaction is often claimed as a surrogate for healthcare quality. This is an incorrect and dishonest assertion and threatens to destroy the doctor-patient relationship at its most sacred juncture—the bedside.

On World AIDS Day, advocates mark "the beginning of the end" of the pandemic. In the United States, 2014 has been marked by battles between patient advocacy groups and some payers over the price of generic HIV drugs on exchanges under the Affordable Care Act.

The part of HealthCare.gov intended for small businesses opened with reports of only modest technical flaws-but with doubts that it will soon benefit the millions of workers at little companies with inadequate health insurance or none at all.

US officials trying to set up a network of hospitals in this country to care for Ebola patients are running into reluctance from facilities worried about steep costs, unwanted attention, and the possibility of scaring away other patients.

A small business owner describes his experience with buying health benefit for his employees through the Affordable Care Act plans.

The NIH-funded study, published in the New England Journal of Medicine, identified mutations that are harbored early and could be potential early-onset biomarkers for detection.

Hospitals in the St. Louis area braced for another violent night Tuesday after at least 25 people were injured in riots triggered by a grand jury's decision not to indict Ferguson, Missouri, police officer Darren Wilson in the fatal shooting of Michael Brown.